"Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis". Alimentary Pharmacology & Therapeutics. 43 (12): 1276-92. June 2016. doi:10.1111/apt.13633. PMID27087015.
"Which therapeutic option for hepatitis C virus genotype 1?". Scandinavian Journal of Gastroenterology. 50 (4): 470-8. April 2015. doi:10.3109/00365521.2014.978364. PMID25396710.
"Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis". Alimentary Pharmacology & Therapeutics. 43 (12): 1276-92. June 2016. doi:10.1111/apt.13633. PMID27087015.
"Which therapeutic option for hepatitis C virus genotype 1?". Scandinavian Journal of Gastroenterology. 50 (4): 470-8. April 2015. doi:10.3109/00365521.2014.978364. PMID25396710.
The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children). Cenevre: World Health Organization. 2019. ISBN9789241210300. ISSN0512-3054. WHO technical report series;1021.